A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/23/2004	US6821997 Associated with a decreased presence of cell-specific carbonic anhydrase enzymes; neurodegenerative conditions, dementia, alzheimer's disease; administering compound to increase ca such as forms of zinc
11/23/2004	US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004	US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004	US6821954 Compounds and uses thereof in treating bone disorders
11/23/2004	US6821953 Methods for treating and preventing damage to mucosal tissue
11/23/2004	US6821951 An echinocandin/carbohydrate complex in an oral formulation to enhance heat resistance/shelf life; desolventizing a solution of an echinocandin or echinocandin/carbohydrate complex and a carbohydrate sprayed on a carrier; fungicides
11/23/2004	US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004	US6821949 Long lasting synthetic glucagon-like peptide (GLP-1)
11/23/2004	US6821948 Conjugate for mediating cell, compartment or membrane-specific transport of active substances
11/23/2004	US6821947 Endorepellin: methods and compositions for inhibiting angiogenesis
11/23/2004	US6821946 Treating nerve damage; administer insulin like growth factor isoform to human, monitor response of damaged nerves
11/23/2004	US6821945 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
11/23/2004	US6821780 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
11/23/2004	US6821774 Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
11/23/2004	US6821767 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
11/23/2004	US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004	US6821753 Replication incompetent herpes viruses for use in gene therapy
11/23/2004	US6821750 ABCG8 vectors, host cells, and method of making
11/23/2004	US6821739 Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens
11/23/2004	US6821736 Human cellular inhibitor of apoptosis proteins (c-iap1/2); binding tumor necrosis factor receptor associated factor (traf); for automatic high throughput drug screening/diagnosis/therapy
11/23/2004	US6821545 Edible, wholly or partially nondigestible low calorie fatty acid polyesters having non-newtonian pseudoplastic rheology at body temperature; substitute for triglyceride fats in low calorie fat-containing foods; for reducing serum cholesterol
11/23/2004	US6821529 Oligo(ethylene glycol)-terminated 3-alkyl-1,2-dithiolane for use as part of support in chemical analysis
11/23/2004	US6821527 Using chronic intermittent intravenous insulin therapy for improving the entire metabolism and through its multiplicity of effects on neurovascular reactivity
11/23/2004	US6821522 Administering to the mammalian host a composition comprising a multivalent nkg2d-binding agent to a tumor expressing native nkg2d
11/23/2004	US6821521 Multicomponent meningococcal vaccine
11/23/2004	US6821520 Local administration of a therapeutically effective amount of a clostridial toxin for therapy of hashimoto's thyroiditis
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	US6821518 Polypeptides encoded by nucleotide sequences preferentially expressed in lung tumor may be used in vaccines and pharmaceutical compositions for treatment and diagnosis of lung cancer
11/23/2004	US6821517 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/23/2004	US6821514 Administering a casomorphinase or a casomorphin ligand microbial casomorphin inhibitor and a gluteomorphinase or a gluteomorphin ligand gluteomorphin inhibitor
11/23/2004	US6821511 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment
11/23/2004	US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004	CA2171963C Dextran esters, the preparation thereof and the use thereof for coating or embedding drugs
11/23/2004	CA2171446C Pseudo- and non-peptide bradykinin receptor antagonists
11/23/2004	CA2164626C Multiple botulinum toxins for treating neuromuscular disorders and conditions
11/23/2004	CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/23/2004	CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts
11/22/2004	CA2441681A1 Cancer monitoring and therapeutics
11/19/2004	CA2465004A1 Composition
11/18/2004	WO2004099784A2 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
11/18/2004	WO2004099782A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
11/18/2004	WO2004099781A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1)
11/18/2004	WO2004099672A2 Non-catalytic combustor for reducing nox emissions
11/18/2004	WO2004099423A1 Vp2-modified raav vectors and uses thereof
11/18/2004	WO2004099410A2 Compound and method for regulating plasminogen activation and cell migration
11/18/2004	WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	WO2004099372A2 Anti-scarring ribozymes and methods
11/18/2004	WO2004099248A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2)
11/18/2004	WO2004099246A2 Peptides for use in treating obesity
11/18/2004	WO2004099244A2 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
11/18/2004	WO2004099239A1 Acylated lysobactin-type nonadepsipeptides
11/18/2004	WO2004099238A1 NOVEL mu-CONOTOXIN PEPTIDES
11/18/2004	WO2004099235A2 Bacteriocins and novel bacterial strains
11/18/2004	WO2004099232A2 Selective r-cadherin antagonists and methods
11/18/2004	WO2004099135A2 Hiv prodrugs cleavable by cd26
11/18/2004	WO2004098714A1 Methods for treating sinus headache
11/18/2004	WO2004098670A1 Method of regenerating tooth germ
11/18/2004	WO2004098648A1 Gene therapy for neurometabolic disorders
11/18/2004	WO2004098644A1 Prodrugs cleavable by cd26
11/18/2004	WO2004098635A1 Glutamate receptor antagonists as neuroprotectives
11/18/2004	WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004	WO2004098633A1 Composition comprising a pde-4 inhibitor and a tnf alpha antagonist
11/18/2004	WO2004098632A1 Skin collagen production promoter
11/18/2004	WO2004098630A1 Menopausal disorder inhibitor
11/18/2004	WO2004098629A1 GnRH CONJUGATES COMPRISING A PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY
11/18/2004	WO2004098628A2 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	WO2004098627A1 Inhibition of platelet aggregation through acyclovir and two peptide antagonists
11/18/2004	WO2004098626A2 The use of a polypeptide domain of slpi to modulate the tumorigenic and metastatic potential of cancer cells
11/18/2004	WO2004098606A1 Composition comprising a pde4 inhibitor and shuil-1r ii
11/18/2004	WO2004098597A1 Composition comprising roflumilast and shuil-1r ii
11/18/2004	WO2004098596A1 Composition comprising roflumilast and il-1 trap
11/18/2004	WO2004098595A1 COMPOSITION COMPRISING ROFLUMILAST AND A TNFα ANTAGONIST
11/18/2004	WO2004098560A1 Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
11/18/2004	WO2004098536A2 Anti-viral activity of cathelicidin peptides
11/18/2004	WO2004098513A2 Nasal administration of the lh-rh analog leuprolide
11/18/2004	WO2004098502A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses.
11/18/2004	WO2004098495A2 Medical devices and methods for inhibiting proliferation of smooth muscle cells
11/18/2004	WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto
11/18/2004	WO2004098310A1 Peptides having an ace inhibiting effect
11/18/2004	WO2004089980A3 Therapeutic cancer vaccine
11/18/2004	WO2004087930A8 Adenovirus replication-competent vectors expressing trail
11/18/2004	WO2004087740A3 Preserved and stable compositions containing peptide copper complexes and methods related thereto
11/18/2004	WO2004085648A3 Nogo receptor binding protein
11/18/2004	WO2004083376A3 Modulators
11/18/2004	WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/18/2004	WO2004078934A8 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer
11/18/2004	WO2004078778A3 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
11/18/2004	WO2004078127A3 Continuous delivery methods for treating hepatitis virus infection
11/18/2004	WO2004078097A8 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
11/18/2004	WO2004069857A3 “peptides, compositions and uses thereof”
11/18/2004	WO2004069193A9 Methods and compositions for inhibiting cholesterol uptake
11/18/2004	WO2004065601A3 Lipophilic derivatives of double-stranded ribonucleic acid
11/18/2004	WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004	WO2004054603A3 Use of beta-defensins for treating hiv infections
11/18/2004	WO2004048591A3 Methods for cohort selection and longevity studies
11/18/2004	WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
11/18/2004	WO2004035083A3 Compositions for the treatment of autoimmune disorders
11/18/2004	WO2004034093A3 Caterpiller gene family
11/18/2004	WO2004027064A3 Ghrh analogues

1 ... 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 ... 3163